Strasbourg response for ERT: Costas Davanis
The World Health Organization (WHO) today asked all vaccine manufacturers who have received significant public funding to share their data and technology to ensure equitable access and increased vaccine production worldwide. He also asked companies to send the Agency the data of their vaccines that are under investigation, so that the WHO can proceed more quickly with the issuance of an emergency license that will help all countries in obtaining licenses.
WHO chief Dr Adhanom Tendros even urged companies to issue non-exclusive licenses to produce their vaccines in order to allow other producers to manufacture their own vaccines using the platform previously used by WHO. To expand access to treatments for HIV and hepatitis C, where scientists shared knowledge, intellectual property and data.
This knowledge and data sharing, as he pointed out, could enable immediate use of untapped capacity and help build additional construction units, especially in Africa, Asia and Latin America. Expanding production globally would also make poor countries less dependent on donations from rich countries.
WHO also asked all pharmaceutical companies to intensify their cooperation to increase vaccine production capacity, following the example of Sanofi, which provided its production infrastructure to support the production of the Pfizer / BioNTech vaccine.
The World Health Organization (WHO) has reiterated its call on countries that complete vaccination of health workers and the elderly to distribute doses of the vaccine to low- and middle-income countries, as so far the Three-quarters of vaccinations have been carried out in just ten countries that represent almost 60% of world GDP, while some 130 countries, with 2.5 billion citizens, have not yet delivered a single quota.
Regarding the reduction of cases worldwide by 13%, the head of technical management of the pandemic Maria van Kerkove stressed that it is due to a combination of factors, including faithful compliance with hygiene measures, health measures public with the imposition of restrictions and vaccination. . In fact, an example of good case management and reduction is India, with a population of 1 billion, which has managed to reduce the number of cases per week from 646,000 to just 91,000 and the death toll from 14,816 to 978.
At the same time, as announced by the WHO, after a meeting of 2,000 scientists, studies and mainly randomized studies will begin to examine hearing and the combination of use of different vaccines, while in the coming days there will be cooperation between pharmaceutical companies and scientists.
Meanwhile, the WHO will proceed with the evaluation for the concession of emergency use of the Astrazeneca vaccine produced in India and Korea on February 15, after first evaluating with technical consultants the data that have been sent to it.
Regarding the conduct of the Olympic Games and the location of Japanese officials that the Games will definitely take place, WHO expressed the belief that both the host country and the International Olympic Committee will assess the situation based on the epidemiological picture. and the ways in which they can be done.